Changeflow GovPing Pharma & Drug Safety EPO Patent EP3645731B1: Process for producing l...
Routine Rule Added Final

EPO Patent EP3645731B1: Process for producing lipids from guayule biomass

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has granted patent EP3645731B1 for a process to produce lipids from guayule biomass. This patent is effective March 18, 2026, and applies to designated European states.

What changed

The European Patent Office (EPO) has granted patent EP3645731B1, titled "A PROCESS FOR THE PRODUCTION OF LIPIDS FROM BIOMASS DERIVED FROM GUAYULE PLANTS." This patent, effective March 18, 2026, covers a specific process for extracting lipids from guayule plant biomass.

This grant represents a new intellectual property right in the biotechnology and pharmaceutical sectors. Companies involved in lipid production or the development of bioprocesses utilizing plant biomass should be aware of this patent's existence and scope, particularly if operating within the designated European states. No immediate compliance actions are required for entities not directly involved in this specific patented process, but it may impact future research and development or commercialization efforts in this area.

Source document (simplified)

← EPO Patent Bulletin

A PROCESS FOR THE PRODUCTION OF LIPIDS FROM BIOMASS DERIVED FROM GUAYULE PLANTS

Grant EP3645731B1 Kind: B1 Mar 18, 2026

Inventors

CUCCHETTI, Daniela, BATTISTEL, Ezio, GAMBARO, Chiara, D'ARMINIO MONFORTE, Alessandra

IPC Classifications

C12N 1/14 20260101AFI20250703BHEP C12P 7/6409 20220101ALI20250703BHEP C12R 1/645 20060101ALI20250703BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

A PROCESS FOR THE PRODUCTION OF LIPIDS FROM BIOMASS DERIVED FROM GUAYULE PLANTS

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3645731B1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Bioprocess Development Lipid Production
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.